Triple Negative Breast Cancer
Did you know that TNBC accounts for approximately 15% of all breast cancers?
60-90% of the tumors in BRCA 1 carries are triple negative.
In a recent study, 18% of unselected patients with triple negative breast cancer had BRCA1/2 mutations.
NCCN Testing criteria includes HBOC syndrome testing for patients with TNBC under age 60.
Source of Information: Myriad Genetics, Inc.
Male Breast Cancer
Multiple professional society guidelines state that a personal or family history of male breast cancer is a criterion for HBOC testing.
1 in 7 Ashkenazi Jewish males diagnosed with breast cancer will have a BRCA mutation. 1 in 14 non-Ashkenazi Jewish males diagnosed with breast cancer will have a BRCA mutation.
Men with BRCA mutations are at increased risk for several types of cancer. These include breast cancer, prostate cancer, pancreatic cancer, and melanoma.
Ovarian Cancer:
Multiple professional society guidelines state that a personal or family history of epithelial ovarian cancer is a criterion for HBOC testing.
55% of ovarian cancer patients at a major US cancer center were not aware of hereditary cancer testing.
89% of patients were willing to be tested if it would affect their therapy and 87% would be tested to benefit their family.
Source: Myraid Lab
1.800.469.7423
Most insurance companies cover testing for patients with a history of the cancer listed. It is important to find out your personal and family history forms to see if you qualify for testing.
